I think Gilead is waiting for the BLA and approval for the mono pivotal trial, I think these are two milestones for CYDY, as for any small company it would be a milestone to submit a BLA. Such milestones raise the stock price, open the door to longer-term financing and facilitate negotiations on a BO or partnership. By all indicators, we are close to the turning point for CYDY, I see it that way, and in my opinion by the end of the year it will be either a BO or a partnership if we make the milestones as we expect.